Boivin GP, O'Toole BA, Ormsby IE, Diebold RJ, Eis MJ, Doetschman T., and Kier AB (1995). Onset and progression of pathologic lesions in TGFB1-deficient mice. Am. J. Pathol. 146: 276-288.
2.
Doetschman T. (1994). Transgenic Animal Technology: Gene Transfer in Embryonic Stem Cells. Academic Press, New York, pp. 115-146.
3.
Giraldi FP, Mizobuchi M., Horowitz ZD, Downs TR, Aleppo G., Kier AB, Wagner T., Yun J., Kopchick JJ, and Frohman LA (1994). Development of neuroepithelial tumors of the adrenal medulla in transgenic mice expressing a mouse hypothalmic growth hormone-releasing hormone promoter-simian virus-40 T-antigen fusion gene. Endocrinology134: 1219-1224.
4.
Kaur S., Singh G., Stock J., Schreiner C., Kier A., Yager K., Mucenski M., Scott W., and Potter S. (1992). Dominant mutation of the murine Hox-2.2 gene results in developmental abnormalities. J. Exp. Zool. 264: 323-336.
5.
Shull MM, Ormsby I., Kier AB, Pawlowski S., Diebold RJ, Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., and Doetschman T. (1992). Targeted disruption of the murine transforming growth factor-B 1 gene results in multifocal inflammatory disease. Nature359: 693-699.
6.
Davisson MT (1990). The Jackson Laboratory Mouse Mutant Resource. Lab. Anim. 19: 23-29.
7.
Davisson MT (1994). Rules and guidelines for genetic nomenclature in mice. Mouse Genome92: VII-XXVII.
8.
Davisson MT (1994). 14 Rules for nomenclature of inbred strains. Mouse Genome92: XXVIII-XXXII.
9.
Davisson MT (1994). Rules and guidelines for genetic nomenclature in mice: Excerpted version-March 1994. Transgenics1: 321-335.
10.
Davisson MT (1994). Rules and guidelines for nomenclature of mouse genes. Gene147: 157-160.
11.
Herbert JM, Rosenquist T., Gotz J., and Martin GR (1994). FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell78: 1017-1025.
12.
Holstein J. (1979). The First Fifty Years at the Jackson Laboratory . The Jackson Laboratory, Bar Harbor , ME.
13.
Mobraaten L. and Neleski L. (1994). The Jackson Laboratory Lane List. The Jackson Laboratory, Bar Harbor, ME.
14.
Nadeau JH, Grant PL, Mankala S., Reiner AH, Richardson JE, and Eppig JT (1995). A rosetta stone of mammalian genetics. Nature (London)373: 363-365.
15.
Peters J. and Cocking Y. (1994). Mouse gene list. Mouse Genome92: 169-299.
16.
Ringwald M. , Baldock R., Bard J., Kaufman M., Eppig JT, Richardson JE, Nadeau JH, and Davidson D. (1994). A database for mouse development. Science265: 2033-2034.
17.
Sharp JJ and Davisson MT (1994). The Jackson Laboratory Induced Mutant Resource . Lab. Anim. 23: 32-40.
18.
Sundberg JP (1989). The Jackson Laboratory-A valuable medical research center. Comp. Pathol. Bull. 21: 1-4.
19.
Sundberg JP (1994). Handbook of Mouse Mutations with Skin and Hair Abnormalities: Animal Models and Biomedical Tools. CRC Press, Boca Raton, FL.
20.
Fernandez-Salguero P., Pineau T., Hilbert DM, Mc- Phail T., Lee SST, Kimura S., Nebert DW, Rudikoff S., Ward JM, and Gonzalez FJ (1995). Immune system impairment and hepatic fibrosis in mice lacking the dioxin-binding Ah receptor. Science268: 722-726.
21.
Lee SST , Pineau T., Drago J., Lee EJ, Owens JW, Kroetz DL, Fernandez-Salguero PM, Westphal H., and Gonzalez FJ (1995). Targeted disruption of the α isoform of the peroxisome proliferator-activated receptor gene in mice results in the abolishment of the pleiotropic effects of peroxisome proliferators. Mol. Cell. Biol. 15: 1312-1322.
22.
Swanson HI and Bradfield CA (1993). The AH-receptor : Genetics, structure and function . Pharmacogenetics3: 213-230.
23.
Ando K., Guidotti LG, Wirth S., Ishikawa T., Missale G., Moriyama T., Schreiber RD, Schlicht HJ, Huang S., and Chisari FV (1994). Class I restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. J. Immunol . 152: 3245-3253.
24.
Chisari FV and Ferrari C. (1995). Hepatitis B virus immunopathogenesis. Ann. Rev. Immunol. 13: 29-60.
25.
Guidotti LG , Ando K., Hobbs MV, Ishikawa T., Runkel RD, Schreiber RD, and Chisari FV (1994). Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proc. Natl. Acad. Sci. USA91: 3764-3768.
26.
Sandgren EP , Luetteke NC, Palmiter RD, Brinster RL, and Lee DC (1990). Overexpression of TGFalpha in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell61: 1121-1135.
27.
Sandgren EP, Luetteke NC, Qiu TH, Palmiter RD, Brinster RL, and Lee DC (1993). Transforming growth factor alpha dramatically enhances oncogene-induced carcinogenesis in transgenic mouse pancreas and liver. Mol. Cell Biol. 113: 320-330.
28.
Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, and Brinster RL (1989). Oncogene-induced liver neoplasia in transgenic mice. Oncogene4: 715-724.
29.
Overbeek PA (1994). Factors affecting transgenic animal production . In: Transgenic Animal TechnologyA Laboratory Handbook, C Pinkert (ed). Academic Press, New York, pp. 69-114.
30.
Taketo M. , Schroeder AC, Mobraaten LE, Gunning KB, Hanten G., Fox RR, Roderick TH, Stewart CL, Lilly F., Hansen CT, and Overbeek PA (1991). FVB/ N: An inbred mouse strain preferable to transgenic analyses. Proc. Natl. Acad. Sci. USA88: 2065-2069.
31.
Sandgren EP, Quaife CJ, Pinkert CA, Palmiter RD, and Brinster RL (1989). Oncogene-induced liver neoplasia in transgenic mice. Oncogene4: 715-724.
32.
Maronpot RR, Palmiter RD, Brinster RL, and Sandgren EP (1991). Pulmonary carcinogenesis in transgenic mice. Exp. Lung Res. 17: 305-320.
33.
Gibson CW, Lally E., Herold RC, Decker S., Brinster RL, and Sandgren EP (1992). Odontogenic tumors in mice carrying albumin-myc and albumin-ras trans-genes. Calcif. Tissue Int. 51: 162-167.
34.
Sandgren EP, Quaife CJ, Paulovich AG, Palmiter RD, and Brinster RL (1991). Pancreatic tumor pathogenesis reflects the causative genetic lesion. Proc. Natl. Acad. Sci. USA88: 93-97.